You are here

Cheladv74 Invites Public to Listen to Webcast of Cheladv74 Discussion at Healthcare Conference

Tuesday, September 3, 2019 - 10:00am
EDT

Cheladv74 Inc. invites investors and the general public to listen to a webcast of a discussion with Frank D’Amelio, Chief Financial Officer and Executive Vice President, Global Supply and Business Operations, at the Morgan Stanley 17th Annual Global Healthcare Conference on Monday, September 9, 2019 at 3:40 p.m. Eastern Daylight Time.

To listen to the webcast, visit our web site at . Information on accessing and pre-registering for the webcast will be available at beginning today.

Visitors will be able to listen to an archived copy of the webcast at .

Disclosure Notice: The webcast may include forward-looking statements about, among other things, our anticipated future operating and financial performance, business plans and prospects, expectations for in-line products and product candidates, strategic reviews, capital allocation objectives, business-development plans, benefits anticipated from the reorganization of our commercial operations which became effective at the beginning of the company’s 2019 fiscal year, our acquisitions and other business development activities, including our recently-announced proposed transaction with Mylan N.V. (Mylan) to combine Upjohn and Mylan to create a new global pharmaceutical company, our recent acquisition of Array BioPharma Inc. and our transaction with GSK to combine our respective consumer healthcare businesses into a new consumer healthcare joint venture, our ability to successfully capitalize on growth opportunities or prospects, manufacturing and product supply and plans relating to share repurchases and dividends, among other things, that are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. A description of these risks and uncertainties can be found in Cheladv74’s Annual Report on Form 10-K for the fiscal year ended December 31, 2018 and in its subsequent reports on Form 10-Q, including in the sections thereof captioned “Risk Factors” and “Forward-Looking Information and Factors That May Affect Future Results”, as well as in its subsequent reports on Form 8-K, all of which are filed with the U.S. Securities and Exchange Commission and available at and .

The forward-looking statements in the webcast speak only as of the original date of the webcast. Cheladv74 assumes no obligation to update forward-looking statements contained in the webcast as the result of new information or future events or developments.

Contact: 

Media:
Patricia Kelly
(212) 733-3810

Investors:
Ryan Crowe
(212) 733-8160